Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome

BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction (Oxford) 2001-07, Vol.16 (7), p.1334-1339
Hauptverfasser: Ekerhovd, E., Enskog, A., Caidahl, K., Klintland, N., Nilsson, L., Brännström, M., Norström, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1339
container_issue 7
container_start_page 1334
container_title Human reproduction (Oxford)
container_volume 16
creator Ekerhovd, E.
Enskog, A.
Caidahl, K.
Klintland, N.
Nilsson, L.
Brännström, M.
Norström, A.
description BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P < 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P < 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.
doi_str_mv 10.1093/humrep/16.7.1334
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70966308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/16.7.1334</oup_id><sourcerecordid>70966308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</originalsourceid><addsrcrecordid>eNqNkEtP3DAUha2qVZnS7ruqvKjYlAx27NjxEhBTKiG1iyIhNtYdx-4YEjvYCWL-fTPNCFh2dV_fOVc6CH2mZEmJYiebsUu2P6FiKZeUMf4GLSgXpChZRd6iBSlFXVAq6AH6kPMdIVNbi_fogFJeVjVRC_T4q4XcATYxGBuGBIOPIePocPC7yeJmTD78wcPG4s6GPKQRWmy2prXHOD5C8hBwHnw3tv-0GELzvN9se5teH_M2NCl29iN656DN9tO-HqLr1cXv88vi6uf3H-enV4XhnAwFKDCcOF4aqaRxZL22ayiZZDWTtALqODjT2Mo0lWLCKMNNXclGNI5KphRnh-ho9u1TfBhtHnTns7FtC8HGMWtJlBCM1BNIZtCkmHOyTvfJd5C2mhK9y1rPWWsqtNS7rCfJl733uO5s8yLYhzsBX_cAZAOtSxCMz6-MOROETti3GYtj_z9fi5n2ebBPzzykey0kk5W-vLnVpBbidqVW-oz9BY6bqYc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70966308</pqid></control><display><type>article</type><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><source>Electronic Journals Library</source><source>MEDLINE</source><source>Oxford Journals Online</source><creator>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</creator><creatorcontrib>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</creatorcontrib><description>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P &lt; 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P &lt; 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</description><identifier>ISSN: 0268-1161</identifier><identifier>ISSN: 1460-2350</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/16.7.1334</identifier><identifier>PMID: 11425809</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Biological and medical sciences ; Chorionic Gonadotropin - administration &amp; dosage ; Embryo Transfer ; Female ; Follicle Stimulating Hormone - administration &amp; dosage ; Fundamental and applied biological sciences. Psychology ; Gonadotropin-Releasing Hormone - administration &amp; dosage ; Humans ; in-vitro fertilization ; Kinetics ; Luteinizing Hormone - metabolism ; Mammalian female genital system ; Menstrual Cycle ; Morphology. Physiology ; nitrate ; Nitrates - blood ; nitric oxide ; ovarian hyperstimulation syndrome ; Ovarian Hyperstimulation Syndrome - blood ; Ovulation ; Ovulation Induction ; Recombinant Proteins - administration &amp; dosage ; Reference Values ; Vertebrates: reproduction</subject><ispartof>Human reproduction (Oxford), 2001-07, Vol.16 (7), p.1334-1339</ispartof><rights>European Society of Human Reproduction and Embryology 2001</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1043601$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11425809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ekerhovd, E.</creatorcontrib><creatorcontrib>Enskog, A.</creatorcontrib><creatorcontrib>Caidahl, K.</creatorcontrib><creatorcontrib>Klintland, N.</creatorcontrib><creatorcontrib>Nilsson, L.</creatorcontrib><creatorcontrib>Brännström, M.</creatorcontrib><creatorcontrib>Norström, A.</creatorcontrib><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><title>Human reproduction (Oxford)</title><addtitle>Hum. Reprod</addtitle><addtitle>Hum. Reprod</addtitle><description>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P &lt; 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P &lt; 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Chorionic Gonadotropin - administration &amp; dosage</subject><subject>Embryo Transfer</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - administration &amp; dosage</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gonadotropin-Releasing Hormone - administration &amp; dosage</subject><subject>Humans</subject><subject>in-vitro fertilization</subject><subject>Kinetics</subject><subject>Luteinizing Hormone - metabolism</subject><subject>Mammalian female genital system</subject><subject>Menstrual Cycle</subject><subject>Morphology. Physiology</subject><subject>nitrate</subject><subject>Nitrates - blood</subject><subject>nitric oxide</subject><subject>ovarian hyperstimulation syndrome</subject><subject>Ovarian Hyperstimulation Syndrome - blood</subject><subject>Ovulation</subject><subject>Ovulation Induction</subject><subject>Recombinant Proteins - administration &amp; dosage</subject><subject>Reference Values</subject><subject>Vertebrates: reproduction</subject><issn>0268-1161</issn><issn>1460-2350</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtP3DAUha2qVZnS7ruqvKjYlAx27NjxEhBTKiG1iyIhNtYdx-4YEjvYCWL-fTPNCFh2dV_fOVc6CH2mZEmJYiebsUu2P6FiKZeUMf4GLSgXpChZRd6iBSlFXVAq6AH6kPMdIVNbi_fogFJeVjVRC_T4q4XcATYxGBuGBIOPIePocPC7yeJmTD78wcPG4s6GPKQRWmy2prXHOD5C8hBwHnw3tv-0GELzvN9se5teH_M2NCl29iN656DN9tO-HqLr1cXv88vi6uf3H-enV4XhnAwFKDCcOF4aqaRxZL22ayiZZDWTtALqODjT2Mo0lWLCKMNNXclGNI5KphRnh-ho9u1TfBhtHnTns7FtC8HGMWtJlBCM1BNIZtCkmHOyTvfJd5C2mhK9y1rPWWsqtNS7rCfJl733uO5s8yLYhzsBX_cAZAOtSxCMz6-MOROETti3GYtj_z9fi5n2ebBPzzykey0kk5W-vLnVpBbidqVW-oz9BY6bqYc</recordid><startdate>20010701</startdate><enddate>20010701</enddate><creator>Ekerhovd, E.</creator><creator>Enskog, A.</creator><creator>Caidahl, K.</creator><creator>Klintland, N.</creator><creator>Nilsson, L.</creator><creator>Brännström, M.</creator><creator>Norström, A.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010701</creationdate><title>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</title><author>Ekerhovd, E. ; Enskog, A. ; Caidahl, K. ; Klintland, N. ; Nilsson, L. ; Brännström, M. ; Norström, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-a9ac40f42c797cf0bbeba237383715a1f4afcde5cd5936c9c4c857d6df1739943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Chorionic Gonadotropin - administration &amp; dosage</topic><topic>Embryo Transfer</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - administration &amp; dosage</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gonadotropin-Releasing Hormone - administration &amp; dosage</topic><topic>Humans</topic><topic>in-vitro fertilization</topic><topic>Kinetics</topic><topic>Luteinizing Hormone - metabolism</topic><topic>Mammalian female genital system</topic><topic>Menstrual Cycle</topic><topic>Morphology. Physiology</topic><topic>nitrate</topic><topic>Nitrates - blood</topic><topic>nitric oxide</topic><topic>ovarian hyperstimulation syndrome</topic><topic>Ovarian Hyperstimulation Syndrome - blood</topic><topic>Ovulation</topic><topic>Ovulation Induction</topic><topic>Recombinant Proteins - administration &amp; dosage</topic><topic>Reference Values</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ekerhovd, E.</creatorcontrib><creatorcontrib>Enskog, A.</creatorcontrib><creatorcontrib>Caidahl, K.</creatorcontrib><creatorcontrib>Klintland, N.</creatorcontrib><creatorcontrib>Nilsson, L.</creatorcontrib><creatorcontrib>Brännström, M.</creatorcontrib><creatorcontrib>Norström, A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ekerhovd, E.</au><au>Enskog, A.</au><au>Caidahl, K.</au><au>Klintland, N.</au><au>Nilsson, L.</au><au>Brännström, M.</au><au>Norström, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome</atitle><jtitle>Human reproduction (Oxford)</jtitle><stitle>Hum. Reprod</stitle><addtitle>Hum. Reprod</addtitle><date>2001-07-01</date><risdate>2001</risdate><volume>16</volume><issue>7</issue><spage>1334</spage><epage>1339</epage><pages>1334-1339</pages><issn>0268-1161</issn><issn>1460-2350</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND: Nitric oxide (NO) is predominantly a locally acting mediator, affecting several functions in the human female reproductive tract. In vivo, it is quickly metabolized to its stable end product nitrate, which is cleared by the kidney. METHODS AND RESULTS: The aim of the present study was to evaluate possible fluctuations of plasma nitrate concentrations during the menstrual cycle, ovarian stimulation as well as ovarian hyperstimulation syndrome (OHSS). During the menstrual cycle (n = 19 women) the mean nitrate concentrations were between 26.7 and 29.5 μmol/l at all stages except for the day of ovulation, when the concentrations were significantly (P &lt; 0.001) increased (mean 37.2 μmol/l ± 2.0). Significantly lower concentrations of plasma nitrate (P &lt; 0.01) were measured at the end of gonadotrophin-releasing hormone (GnRH) down-regulation (24.6 μmol/l ± 1.4) compared with the concentrations found at day 8 of follicle-stimulating hormone (FSH) stimulation (34.9 μmol/l ± 2.6) and at the day of human chorionic gonadotrophin (HCG) (35.6 μmol/l ± 3.3). The concentrations of nitrate (33.4 μmol/l ± 3.4) in women with OHSS (n = 13) were similar to those seen 5 days after embryo transfer (33.2 μmol/l ± 2.3). CONCLUSIONS: The results indicate that NO synthesis is increased at the time of spontaneous ovulation. GnRH treatment inhibits NO synthesis, while NO production is not increased in women with OHSS.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>11425809</pmid><doi>10.1093/humrep/16.7.1334</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2001-07, Vol.16 (7), p.1334-1339
issn 0268-1161
1460-2350
1460-2350
language eng
recordid cdi_proquest_miscellaneous_70966308
source Electronic Journals Library; MEDLINE; Oxford Journals Online
subjects Adult
Biological and medical sciences
Chorionic Gonadotropin - administration & dosage
Embryo Transfer
Female
Follicle Stimulating Hormone - administration & dosage
Fundamental and applied biological sciences. Psychology
Gonadotropin-Releasing Hormone - administration & dosage
Humans
in-vitro fertilization
Kinetics
Luteinizing Hormone - metabolism
Mammalian female genital system
Menstrual Cycle
Morphology. Physiology
nitrate
Nitrates - blood
nitric oxide
ovarian hyperstimulation syndrome
Ovarian Hyperstimulation Syndrome - blood
Ovulation
Ovulation Induction
Recombinant Proteins - administration & dosage
Reference Values
Vertebrates: reproduction
title Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A31%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20concentrations%20of%20nitrate%20during%20the%20menstrual%20cycle,%20ovarian%20stimulation%20and%20ovarian%20hyperstimulation%20syndrome&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=Ekerhovd,%20E.&rft.date=2001-07-01&rft.volume=16&rft.issue=7&rft.spage=1334&rft.epage=1339&rft.pages=1334-1339&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/16.7.1334&rft_dat=%3Cproquest_cross%3E70966308%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70966308&rft_id=info:pmid/11425809&rft_oup_id=10.1093/humrep/16.7.1334&rfr_iscdi=true